Woman accountant or banker use calculator and computer on table
23 March 2020

COVID-19 – Tax Relief Measures

THE CORONA CRISIS IS A HEAVY BURDEN ON CERTAIN GERMAN BUSINESSES. THE GOVERNMENT AND THE FEDERAL STATES HAVE NOW DECIDED TO GRANT TAX EXEMPTIONS TO THOSE AFFECTED.

On 19 March 2020, the Federal Ministry of Finance (BMF) and the highest tax authorities of the federal states took action in order to mitigate the consequences of the current corona crisis for all taxpayers and companies operating in Germany. The Finance Ministry sent out a letter in this regard and the tax authorities of the federal states issued a decree of identical content. The relief measures aim in particular at maintaining liquidity during the crisis and at avoiding additional strain on companies due to tax payments. Beyond that, tax optimisation can be an additional way of making it through this crisis using existing regulations (i.e. tax-free restructuring income) and tax-efficient restructuring measures.

Print


Press contact
presse@gsk.de
+49 30 203907-7763

Back

GSK Updates
  • 24 June 2022

    GSK Update: Accelerated construction of LNG terminals in Germany

    Read more
  • 06 May 2022

    GSK Update: Whistleblowing 2.0: What will the second draft of the Whistleblower Protection Act bring along?

    Read more
  • 25 April 2022

    GSK Update: Ban on public contracts with Russian companies

    Read more
Contact person

Dr. Dirk Koch

Partner*

+49 89 288174-676

dirk.koch@gsk.de

Dr. Petra Eckl

Partner*

+49 69 710003-0

petra.eckl@gsk.de

Dominik Berka

Counsel

+49 69 710003-194

dominik.berka@gsk.de

Felix Schill, LL.M.

Senior Associate

+49 69 710003-199

felix.schill@gsk.de

* Partner: a partner within the meaning of the German Partnership Companies Act.
   Local Partner: not a partner within the meaning of the German Partnership Companies Act.
CO2 Neutral